Viewing Study NCT06046495


Ignite Creation Date: 2025-12-24 @ 2:11 PM
Ignite Modification Date: 2026-05-08 @ 9:17 AM
Study NCT ID: NCT06046495
Status: RECRUITING
Last Update Posted: 2025-04-23
First Post: 2023-09-06
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study of the Oral EGFR Inhibitor PLB1004 in Non-Small Cell Lung Cancer
Sponsor: Avistone Biotechnology Co., Ltd.
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Non-Small Cell Lung Cancer View
Keywords: